Informatica (INFA) 10-Q 2 May 24 2024 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2024	Apr. 24, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-40936
Entity Registrant Name	Informatica Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	61-1999534
Entity Address, Address Line One	2100 Seaport Boulevard
Entity Address, City or Town	Redwood City
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94063
City Area Code	(650)
Local Phone Number	385-5000
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	INFA
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001868778
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Amendment Flag	false
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		255,584,319
Class B-1 Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		44,049,523

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 855,068	$ 732,443
Short-term investments	258,219	259,828
Accounts receivable, net of allowances of $4,669 and $4,414, respectively	274,724	500,068
Contract assets, net	85,953	79,864
Prepaid expenses and other current assets	226,072	180,383
Total current assets	1,700,036	1,752,586
Property and equipment, net	147,572	149,266
Operating lease right-of-use-assets	55,136	57,799
Goodwill	2,349,119	2,361,643
Deferred tax assets	15,322	15,237
Other assets	165,577	178,377
Total assets	5,084,914	5,202,082
Current liabilities:
Accounts payable	20,084	18,050
Accrued liabilities	52,706	61,194
Accrued compensation and related expenses	77,956	167,427
Current operating lease liabilities	15,701	16,411
Current portion of long-term debt	18,750	18,750
Income taxes payable	2,916	4,305
Deferred revenue	708,568	767,244
Total current liabilities	896,681	1,053,381
Long-term operating lease liabilities	43,255	46,003
Long-term deferred revenue	13,502	19,482
Long-term debt, net	1,802,033	1,805,960
Deferred tax liabilities	21,817	22,425
Long-term income taxes payable	37,840	37,679
Other liabilities	6,971	4,554
Total liabilities	2,822,099	2,989,484
Commitments and contingencies
Stockholders’ equity:
Additional paid-in-capital	3,601,372	3,540,502
Accumulated other comprehensive loss	(42,391)	(22,370)
Accumulated deficit	(1,299,162)	(1,308,484)
Total stockholders’ equity	2,262,815	2,212,598
Total liabilities and stockholders’ equity	5,084,914	5,202,082
Customer relationships
Current assets:
Intangible assets, net	639,078	669,781
Other intangible assets, net
Current assets:
Intangible assets, net	13,074	17,393
Class A Common Stock
Stockholders’ equity:
Common stock, value, issued	2,556	2,510
Class B-1 Common Stock
Stockholders’ equity:
Common stock, value, issued	440	440
Class B-2 Common Stock
Stockholders’ equity:
Common stock, value, issued	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Accounts receivable, allowance	$ 4,669	$ 4,414
Class A Common Stock
Stockholders’ equity:
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, shares, issued (in shares)	255,502,000	250,874,000
Common stock, shares, outstanding (in shares)	255,502,000	250,874,000
Class B-1 Common Stock
Stockholders’ equity:
Common stock, par value per share (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares, issued (in shares)	44,050,000	44,050,000
Common stock, shares, outstanding (in shares)	44,050,000	44,050,000
Class B-2 Common Stock
Stockholders’ equity:
Common stock, par value per share (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	200,000,000	200,000,000
Common stock, shares, issued (in shares)	44,050,000	44,050,000
Common stock, shares, outstanding (in shares)	44,050,000	44,050,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 388,607	$ 365,431
Amortization of acquired technology	1,034	2,874
Total cost of revenues	81,755	81,897
Gross profit	306,852	283,534
Operating expenses:
Research and development	79,654	82,039
Sales and marketing	137,433	128,538
General and administrative	50,446	41,360
Amortization of intangible assets	31,739	34,291
Restructuring	4,355	27,253
Total operating expenses	303,627	313,481
Income (loss) from operations	3,225	(29,947)
Interest income	13,407	7,583
Interest expense	(39,097)	(35,051)
Other income, net	6,335	630
Loss before income taxes	(16,130)	(56,785)
Income tax (benefit) expense	(25,464)	59,569
Net income (loss)	$ 9,334	$ (116,354)
Net income (loss) per share attributable to Class A and Class B-1 common stockholders
Basic (in dollars per share)	$ 0.03	$ (0.41)
Diluted (in dollars per share)	$ 0.03	$ (0.41)
Weighted-average shares used in computing net income (loss) per share
Basic (in shares)	296,897	284,886
Diluted (in shares)	312,499	284,886
Software revenue
Revenues:
Total revenues	$ 251,998	$ 214,728
Cost of revenues:	46,843	35,864
Subscriptions
Revenues:
Total revenues	251,977	213,922
Cost of revenues:	46,838	35,684
Perpetual license
Revenues:
Total revenues	21	806
Cost of revenues:	5	180
Maintenance and professional services
Revenues:
Total revenues	136,609	150,703
Cost of revenues:	$ 33,878	$ 43,159

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 9,334	$ (116,354)
Other comprehensive (loss) income, net of taxes:
Change in foreign currency translation adjustment, net of tax benefit of $206 and $228	(19,980)	11,750
Available-for-sale debt securities:
Change in unrealized (loss) gain, net of tax benefit (expense) of $26 and $(24)	(81)	74
Cash flow hedges:
Change in unrealized gain, net of tax expense of $88 and $308	269	941
Less: reclassification adjustment for amounts included in net income (loss), net of tax (expense) benefit of $(75) and $286	(229)	874
Cash flow hedges, net change	40	1,815
Total other comprehensive (loss) income, net of tax effect	(20,021)	13,639
Total comprehensive loss, net of tax effect	$ (10,687)	$ (102,715)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Change in foreign currency translation adjustment, tax	$ 206	$ 228
Change in unrealized (loss) gain, net of tax expense	26	(24)
Change in unrealized gain, net of tax expense	(88)	(308)
Reclassification adjustment for amounts included in net income (loss), net of tax benefit	$ (75)	$ 286

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Class A Common Stock	Class B-1 Common Stock	Class B-2 Common Stock	Common Stock Class A Common Stock	Common Stock Class B-1 Common Stock	Common Stock Class B-2 Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022					239,749,000	44,050,000	44,050,000
Beginning balance at Dec. 31, 2022	$ 2,054,361				$ 2,398	$ 440	$ 0	$ 3,282,383	$ (47,671)	$ (1,183,189)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	50,342							50,342
Issuance of shares under employee stock purchase plan (in shares)					1,112,000
Issuance of shares under employee stock purchase plan	16,131				$ 11			16,120
Issuance of shares under equity plans (in shares)					1,361,000
Issuance of shares under equity plans	3,481				$ 14			3,467
Payments for dividends related to Class B-2 shares	(12)									(12)
Net income (loss)	(116,354)									(116,354)
Other comprehensive (loss) income	13,639								13,639
Ending balance (in shares) at Mar. 31, 2023					242,222,000	44,050,000	44,050,000
Ending balance at Mar. 31, 2023	2,021,588				$ 2,423	$ 440	$ 0	3,352,312	(34,032)	(1,299,555)
Beginning balance (in shares) at Dec. 31, 2023		250,874,000	44,050,000	44,050,000	250,874,000	44,050,000	44,050,000
Beginning balance at Dec. 31, 2023	2,212,598				$ 2,510	$ 440	$ 0	3,540,502	(22,370)	(1,308,484)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	64,101							64,101
Issuance of shares under employee stock purchase plan (in shares)					936,000
Issuance of shares under employee stock purchase plan	13,797				$ 9			13,788
Shares withheld related to net share settlement of equity awards (in shares)					(1,350,000)
Shares withheld related to net share settlement of equity awards	(45,843)				$ (14)			(45,829)
Issuance of shares under equity plans (in shares)					5,042,000
Issuance of shares under equity plans	28,861				$ 51			28,810
Payments for dividends related to Class B-2 shares	(12)									(12)
Net income (loss)	9,334									9,334
Other comprehensive (loss) income	(20,021)								(20,021)
Ending balance (in shares) at Mar. 31, 2024		255,502,000	44,050,000	44,050,000	255,502,000	44,050,000	44,050,000
Ending balance at Mar. 31, 2024	$ 2,262,815				$ 2,556	$ 440	$ 0	$ 3,601,372	$ (42,391)	$ (1,299,162)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net income (loss)	$ 9,334	$ (116,354)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	2,193	4,198
Non-cash operating lease costs	3,902	5,350
Stock-based compensation	64,101	50,342
Deferred income taxes	(831)	11,477
Amortization of intangible assets and acquired technology	32,773	37,165
Amortization of debt issuance costs	887	847
Amortization of investment discount, net of premium	(1,440)	(851)
Changes in operating assets and liabilities:
Accounts receivable	220,708	197,579
Prepaid expenses and other assets	(233)	10,983
Accounts payable and accrued liabilities	(97,023)	(118,076)
Income taxes payable	(43,507)	22,184
Deferred revenue	(59,222)	(34,962)
Net cash provided by operating activities	131,642	69,882
Investing activities:
Purchases of property and equipment	(390)	(1,224)
Purchases of investments	(146,997)	(30,297)
Maturities of investments	149,939	80,500
Other	1,878	0
Net cash provided by investing activities	4,430	48,979
Financing activities:
Payment of debt	(4,688)	(4,688)
Proceeds from issuance of common stock under employee stock purchase plan	13,797	16,131
Payments for dividends related to Class B-2 shares	(12)	(12)
Payments for taxes related to net share settlement of equity awards	(45,843)	0
Proceeds from issuance of shares under equity plans	28,861	3,481
Net cash (used in) / provided by financing activities	(7,885)	14,912
Effect of foreign exchange rate changes on cash and cash equivalents	(5,562)	1,255
Net increase in cash and cash equivalents	122,625	135,028
Cash and cash equivalents at beginning of period	732,443	497,879
Cash and cash equivalents at end of period	855,068	632,907
Supplemental disclosures:
Cash paid for interest	37,782	34,482
Cash paid for income taxes, net of refunds	18,873	25,907
Non-cash investing and financing activities:
Purchases of property and equipment recorded in accounts payable and accrued liabilities	$ 875	$ 1,273

Organization and Description of

Organization and Description of Business	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Note 1. Organization and Description of Business Informatica Inc. (the “Company” or “Informatica”) delivers data management products powered by an artificial intelligence ("AI") platform that connects, manages, and unifies data across multi-vendor, multi-cloud, hybrid systems at enterprise scale. The platform enables the Company’s customers to accurately track and understand their data, allowing them to create 360-degree customer experiences, automate data operations across enterprise-wide business processes, and pursue holistic data-driven digital strategies by guiding workload migrations to the cloud. The Company’s platform includes a suite of interoperable data management products that leverage the shared services and metadata of the underlying platform, including products for Data Catalog, Data Integration & Engineering, API & Application Integration, Data Quality and Observability, Master Data Management, Customer and Business 360 Applications, Governance and Privacy, and Data Marketplace. The Company was incorporated as a Delaware corporation on June 4, 2021.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Note 2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements include those of the Company and its subsidiaries, after elimination of all intercompany accounts and transactions. The Company has prepared the accompanying unaudited condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”). In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include recurring adjustments necessary for the fair statement of the Company’s financial position as of March 31, 2024 and the results of operations for the three months ended March 31, 2024. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. Segment Reporting The Company manages, monitors and reports its operating results and financial position as a single operating segment. The Company’s chief operating decision-maker (“CODM”) is its Chief Executive Officer who makes operating decisions, assesses financial performance and allocates resources based on consolidated financial information. As such, the Company has determined that it operates in one reportable segment. Use of Estimates The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP, which require management to make certain estimates, judgments, and assumptions in determination of performance obligations and standalone selling price used in revenue recognition, the realizability of deferred tax assets, uncertain tax positions, and stock-based compensation. Management believes the estimates, judgments, and assumptions upon which it relies are reasonable based on information available at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. Any material differences between these estimates and actual results will impact the Company’s unaudited condensed consolidated financial statements. The Company assesses these estimates on a regular basis, however actual results could differ from estimates due to risks and uncertainties. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in “ Note 2. Basis of Presentation and Summary of Significant Accounting Policies ” of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on February 22, 2024. There have been no material changes to these policies during the three months ended March 31, 2024. Recent Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

Cash, Cash Equivalents, and Inv

Cash, Cash Equivalents, and Investments	3 Months Ended
	Mar. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Investments	Note 3. Cash, Cash Equivalents, and Investments The following table summarizes the Company’s cash, cash equivalents and investments as of March 31, 2024 and December 31, 2023 (in thousands). March 31, December 31, 2024 2023 Cash $ 176,516 $ 185,498 Cash equivalents: Time deposits 201,558 72,302 Money market funds 476,994 474,643 Total cash equivalents 678,552 546,945 Total cash and cash equivalents $ 855,068 $ 732,443 Short-term investments: Time deposits 150,805 153,550 Commercial paper 74,519 73,767 Corporate debt securities 3,986 3,964 U.S. government and agency securities 28,909 28,547 Total short-term investments $ 258,219 $ 259,828 Total cash, cash equivalents and investments $ 1,113,287 $ 992,271 See Note 5. Fair Value Measurements of the Notes to Condensed Consolidated Financial Statements of this Report for further information regarding the fair value of the Company’s financial instruments.

Available-For-Sale Debt Securit

Available-For-Sale Debt Securities	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Available-For-Sale Debt Securities	Note 4. Available-For-Sale Debt Securities The following table summarizes the Company’s available-for-sale debt securities as of March 31, 2024 (in thousands). March 31, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. government securities $ 28,914 $ — $ (5) $ 28,909 Corporate debt securities 3,987 — (1) 3,986 Commercial paper 74,551 14 (46) 74,519 Total $ 107,452 $ 14 $ (52) $ 107,414 The following table summarizes the Company’s available-for-sale debt securities as of December 31, 2023 (in thousands). December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. government securities $ 18,596 $ 5 $ — $ 18,601 U.S. government agency securities 9,949 — (3) 9,946 Corporate debt securities 3,963 1 — 3,964 Commercial paper 73,701 76 (10) 73,767 Total $ 106,209 $ 82 $ (13) $ 106,278 There were no realized gains or losses related to available-for-sale debt securities for the three months ended March 31, 2024. As of March 31, 2024, the fair value of the Company’s available-for-sale debt securities with contractual maturity of one year or less from the condensed consolidated balance sheet date was $107.4 million. As of March 31, 2024, the gross unrealized losses that have been in a continuous unrealized loss position for less than 12 months were less than $0.1 million, which were related to $77.2 million of available-for-sale debt securities. There were no gross unrealized losses that have been in a continuous unrealized loss position for more than 12 months. The Company did not recognize any credit losses related to the Company’s debt securities during the three months ended March 31, 2024. Unrealized losses related to available-for-sale debt securities are due to interest rate fluctuations as opposed to credit quality. The Company does not intend to sell these investments. In addition, it is more likely than not that the Company will not be required to sell them before recovery of the amortized cost basis, which may be at maturity.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 5. Fair Value Measurements The Company uses a three-level fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based on whether the inputs to those valuation techniques are observable or unobservable. The three levels of fair value hierarchy are set forth below. The Company’s assessment of the hierarchy level of the assets or liabilities measured at fair value is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Level 1 Quoted prices in active markets for identical assets or liabilities. Level 2 Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 Unobservable inputs that are supported by little or no market activity and that are significant to the fair values of the assets or liabilities. The Company does not have any assets or liabilities classified as Level 3. Fair Value Measurement of Financial Assets and Liabilities on a Recurring Basis The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of March 31, 2024 and indicates the fair value hierarchy of the valuation (in thousands): Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Time deposits $ 352,363 $ 352,363 $ — $ — Money market funds 476,994 476,994 — — Commercial paper 74,519 — 74,519 — Corporate debt securities 3,986 — 3,986 — U.S. government securities 28,909 — 28,909 — Total cash equivalents and investments 936,771 829,357 107,414 — Foreign currency derivatives 434 — 434 — Total assets $ 937,205 $ 829,357 $ 107,848 $ — Liabilities: Foreign currency derivatives $ 13 $ — $ 13 $ — Total liabilities $ 13 $ — $ 13 $ — There were no transfers between Level 1, Level 2 and Level 3 categories during the three months ended March 31, 2024. The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of December 31, 2023 and indicates the fair value hierarchy of the valuation (in thousands): Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Time deposits $ 225,852 $ 225,852 $ — $ — Money market funds 474,643 474,643 — — Commercial paper 73,767 — 73,767 — Corporate debt securities 3,964 — 3,964 — U.S. government and U.S. government agency securities 28,547 — 28,547 — Total cash equivalents and investments 806,773 700,495 106,278 — Foreign currency derivatives 486 — 486 — Total assets $ 807,259 $ 700,495 $ 106,764 $ — Liabilities: Foreign currency derivatives $ 44 $ — $ 44 $ — Total liabilities $ 44 $ — $ 44 $ —

Goodwill and Intangible Assets

Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Note 6. Goodwill and Intangible Assets Goodwill The following table presents the changes in the carrying amount of the goodwill for the three months ended March 31, 2024 (in thousands): Amount Ending balance as of December 31, 2023 $ 2,361,643 Foreign currency translation adjustment (12,524) Ending Balance as of March 31, 2024 $ 2,349,119 Goodwill represents the excess of consideration paid over the estimated fair value of net tangible and identifiable intangible assets acquired in business combinations. Intangible Assets The carrying amounts of the intangible assets other than goodwill as of March 31, 2024 and December 31, 2023 are as follows (in thousands): March 31, 2024 December 31, 2023 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Acquired developed and core technology $ 880,694 $ (872,119) $ 8,575 $ 880,758 $ (871,085) $ 9,673 Other intangible assets: Customer relationships 2,157,036 (1,517,958) 639,078 2,159,179 (1,489,398) 669,781 Trade names and trademark 81,609 (77,110) 4,499 81,651 (73,931) 7,720 Total other intangible assets 2,238,645 (1,595,068) 643,577 2,240,830 (1,563,329) 677,501 Total intangible assets, net $ 3,119,339 $ (2,467,187) $ 652,152 $ 3,121,588 $ (2,434,414) $ 687,174 The Company amortizes its intangible assets over their remaining estimated useful life using cash flow projections, revenue projections, or the straight-line method. Total amortization expense related to intangible assets was $32.8 million and $37.2 million for the three months ended March 31, 2024 and 2023, respectively. The allocation of the amortization of intangible assets for the periods indicated below is as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 1,034 $ 2,874 Operating expenses 31,739 34,291 Total amortization of intangible assets $ 32,773 $ 37,165 Certain intangible assets are recorded in foreign currencies; and therefore, the gross carrying amount and accumulated amortization are subject to foreign currency translation adjustments. As of March 31, 2024, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows (in thousands): Customer Relationships Intangible Asset Other Intangible Assets Total Intangible Assets Remaining 2024 $ 85,563 $ 7,367 $ 92,930 2025 99,611 2,127 101,738 2026 86,608 1,427 88,035 2027 75,156 686 75,842 2028 65,300 530 65,830 Thereafter 226,840 937 227,777 Total expected amortization expense $ 639,078 $ 13,074 $ 652,152

Borrowings

Borrowings	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Borrowings	Note 7. Borrowings Long-term debt consists of the following (in thousands): March 31, 2024 December 31, 2023 Dollar term loan $ 1,837,500 $ 1,842,188 Less: Discount on term loan (6,161) (6,441) Less: Debt issuance costs (10,556) (11,037) Total debt, net of discount and debt issuance costs 1,820,783 1,824,710 Less: Current portion of long-term debt (18,750) (18,750) Long-term debt, net of current portion $ 1,802,033 $ 1,805,960 As of March 31, 2024 and December 31, 2023, the aggregate fair value of the Company’s dollar term loan, based on Level 2 inputs related to fair market value, was $1,841.2 million and $1,848.3 million, respectively. Credit Facilities The Company has a credit agreement with JPMorgan Chase Bank, N.A., as agent, for a syndicate of lenders (the “Credit Agreement”). Under the Credit Agreement, the Company borrowed $1.9 billion of dollar term loans (the “Term Facility”) and obtained $250.0 million of commitments under a revolving credit facility (the “Revolving Facility” and, together with the Term Facility, the “Credit Facilities”). The Term Facility matures on October 29, 2028 and is repayable in quarterly installments of 0.25% of the initial principal amount thereof, with the remaining amount due at maturity. The Revolving Facility matures on October 29, 2026. The Company may prepay all or part of the Credit Facilities at any time. Subject to certain exceptions and limitations, the Company is required to prepay the Term Facility with the net proceeds of certain occurrences, such as the incurrences of indebtedness not permitted to be incurred under the Credit Agreement, credit sale and leaseback transactions and asset sales. The agreement also requires mandatory prepayments of the Term Facility with excess cash flow as specified in the terms of the Credit Agreement. Effective July 1, 2023, the borrowings under the Term Facility bear interest, at the Company’s option, either at (i) Term SOFR 1 with a credit adjustment of 0.11448% to 0.71513% depending on the interest period selected (“Adjusted Term SOFR”) plus 2.75% or (ii) the base rate plus 1.75%. The base rate is defined as the highest of (a) the Federal Funds Rate plus one half of 1%, (b) the rate of interest in effect for such day as published by the Wall Street Journal as the “prime rate,” and (c) Adjusted Term SOFR Rate for a one-month interest period plus 1.00%; provided that the base rate shall not be less than 1.00% per annum. Term SOFR is subject to a “floor” of 0% per annum. The Term Facility was issued with 0.125% of original issue discount. Effective July 1, 2023, the Revolving Facility accrues interest at a per annum rate based on either, at the Company’s election, (i) Term SOFR plus the applicable margin for Term SOFR loans ranging between 2.50% and 2.00% based on the Company’s total net first lien leverage ratio or (ii) the base rate plus an applicable margin ranging between 1.50% and 1.00% based on the Company’s total net first lien leverage ratio. No amounts were outstanding under the Revolving Facility as of March 31, 2024 and December 31, 2023. There were $1.6 million and $1.6 million of utilized letters of credit under the Revolving Facility at March 31, 2024 and December 31, 2023, respectively. The Company guarantees the obligations under the Credit Agreement. All obligations under the Credit Agreement are secured by a perfected lien or security interest in substantially all of the Company’s and the guarantors’ tangible and intangible assets. The Credit Agreement also provides for a borrowing facility of $15.0 million, which is available on a same day basis and a letter of credit facility of $30.0 million. The Credit Agreement also includes an uncommitted incremental facility subject to compliance with certain leverage tests and borrowing limits. Accrued interest is payable (i) quarterly in arrears with respect to base rate loans, (ii) at the end of each interest rate period (or at each three-month interval in the case of loans with interest periods greater than 3 months) with respect to Term SOFR loans, (iii) the date of any repayment or prepayment, and (iv) at maturity (whether by acceleration or otherwise). The Company is also obligated to pay other customary closing fees, arrangement fees, administrative fees, commitment fees, and letter of credit fees. Under the Credit Agreement, a commitment fee is payable on the daily unutilized amount under the Revolving Facility at a per annum rate ranging from 0.35% to 0.25% depending on the Company’s total net first lien leverage ratio. The Credit Agreement requires that, as of the last day of any fiscal quarter if on such date the aggregate principal amount of all (a) revolving loans, (b) swingline loans, and (c) letter of credit obligations (in excess of $15 million) exceed 35% of the revolving loan commitments, the total net first lien leverage ratio cannot exceed 6.25 to 1.00. The occurrence of an event of default could result in the acceleration of the obligations under the Credit Agreement. Under certain circumstances, a default interest rate equal to 2.00% above the then-applicable interest rate will apply during the existence of an event of default under the Credit Agreement. The Company was in compliance with all covenants under the Credit Agreement as of March 31, 2024. The Credit Agreement, among other things, limits the ability of the Company and its restricted subsidiaries to incur or guarantee additional indebtedness; pay dividends or make distributions or redeem or repurchase capital stock; prepay, redeem or repurchase certain subordinated debt; make certain loans or investments; create liens; merge or consolidate with another company or transfer or sell assets; enter into restrictions affecting the ability of certain restricted subsidiaries to make distributions, loans or advances to the Company or its restricted subsidiaries; and engage in transactions with affiliates. These covenants are subject to a number of important limitations and exceptions, which are described in the Credit Agreement. Future minimum principal payments Future minimum principal payments on the Term Facility as of March 31, 2024 are as follows (in thousands): Remaining 2024 $ 14,062 2025 18,750 2026 18,750 2027 18,750 2028 1,767,188 Total $ 1,837,500

Disaggregation of Revenue, Defe

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract	Note 8. Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract The following table presents the disaggregation of revenue by revenue type, consistent with how the Company evaluates its financial performance, for the three months ended March 31, 2024 and 2023 (in thousands): Three Months Ended March 31, 2024 2023 Revenues: Cloud subscription $ 151,438 $ 111,778 Self-managed subscription license 51,948 50,549 Self-managed subscription support and other 48,591 51,595 Subscription revenues 251,977 213,922 Perpetual license 21 806 Software revenue 251,998 214,728 Maintenance 117,678 125,375 Professional services 18,931 25,328 Maintenance and professional services revenue 136,609 150,703 Total revenues $ 388,607 $ 365,431 Revenue by geographic location for the three months ended March 31, 2024 and 2023 (in thousands): Three Months Ended March 31, 2024 2023 North America $ 258,055 $ 251,037 EMEA 86,710 77,002 Asia Pacific 32,980 29,596 Latin America 10,862 7,796 Total revenues $ 388,607 $ 365,431 In the three months ended March 31, 2024 and 2023, the Company’s revenue from customers in the United States was $242.0 million and $233.3 million, respectively. No foreign country represented 10% or more of the Company’s total revenue during the three months ended March 31, 2024 and 2023, respectively. Deferred Revenue As of March 31, 2024 and December 31, 2023, deferred revenue was $722.1 million and $786.7 million, respectively. The amount of revenues recognized during the three months ended March 31, 2024 that were included in the opening deferred revenue balance as of January 1, 2024 was approximately $295.3 million. The amount of revenues recognized during the three months ended March 31, 2023 that were included in the opening deferred revenue balance as of January 1, 2023 was approximately $251.6 million. Remaining Performance Obligations from Customer Contracts As of March 31, 2024, the Company’s remaining performance obligations were $1.5 billion. The Company expects to recognize approximately 66% of its remaining performance obligations at March 31, 2024 as revenues over the next twelve months and the remainder over the next two to three years. Concentrations of Credit Risk and Credit Evaluations No customer accounted for more than 10% of revenue during the three months ended March 31, 2024 and 2023. At March 31, 2024 and December 31, 2023, no customer accounted for more than 10% of the accounts receivable balance. Capitalized Costs to Obtain a Contract Capitalized costs to obtain contracts consist of sales commissions and related payroll taxes (together “deferred commissions”). The changes in the capitalized costs to obtain a contract for the three months ended March 31, 2024 (in thousands): Amount Ending balance as of December 31, 2023 $ 237,991 Additions, net 11,583 Commissions amortized (20,453) Revaluation (1,746) Ending balance as of March 31, 2024 $ 227,375 As of March 31, 2024, $77.0 million of deferred commissions balance was included in prepaid expense and other current assets and $150.4 million of deferred commissions balance was included in other assets in the condensed consolidated balance sheet.

Restructuring

Restructuring	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Note 9. Restructuring On January 10, 2023, the Company announced a plan to reduce its workforce by approximately 450 employees, representing approximately 7% of the Company’s then-current global workforce, and a closure of an office in Israel (the “January Plan”). The January Plan was intended to better align the Company’s global workforce and cost base with its cloud-only, consumption-driven ("CoCd") strategy and related business needs. As of December 31, 2023, the Company recorded $28.2 million of restructuring expenses in relation to the January Plan, including $1.1 million related to the right-of-use assets impairment charge for the office closure. These costs were paid as of December 31, 2023. On November 1, 2023, the Company announced a plan to reduce its workforce by approximately 500 employees, representing approximately 10% of the Company’s then-current global workforce, and reduce its global real estate footprint (the “November Plan”). The November Plan was intended to further streamline the Company’s cost structure as a direct result of the CoCd strategy announced in January 2023. For the year-ended December 31, 2023, the Company recorded $31.6 million of restructuring expenses in relation to the November Plan, including $0.4 million related to the right-of-use assets impairment charge for the reduction in office space. For the three months ended March 31, 2024, the Company recorded $4.3 million of restructuring expenses in relation to the November Plan, including $0.5 million related to the right-of-use assets impairment charge for the reduction in office space. Of the total charges incurred under the November Plan, $29.9 million was paid as of March 31, 2024 and the Company expects to substantially pay the remaining amount in 2024.

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Note 10. Derivative Financial Instruments The Company’s earnings and cash flows are subject to market risks as a result of foreign currency exchange rate and interest rate fluctuations. The Company uses derivative financial instruments to manage its exposure to foreign currency exchange rate which is inherent to its ongoing business operations. The Company and its subsidiaries do not enter into derivative contracts for speculative purposes. Foreign Exchange Forward Contracts The Company enters into foreign exchange forward contracts in an attempt to reduce the impact of foreign currency exchange rate fluctuations and designates these contracts as cash flow hedges at inception. The objective is to reduce the volatility of forecasted cash flows and expenses caused by movements in foreign currency exchange rates, in particular the Indian rupee. The Company is currently using foreign exchange forward contracts to hedge the anticipated foreign currency expenses of its subsidiary in India. The Company recognizes in earnings amounts related to its designated cash flow hedges accumulated in other comprehensive income during the same period in which the corresponding underlying hedged transaction affects earnings. As of March 31, 2024, a net unrealized gain of approximately $0.3 million accumulated in other comprehensive income (loss) is expected to be reclassified into earnings within the next twelve months. The Company has forecasted the amount of its anticipated foreign currency expenses based on its historical performance and projected financial plan. As of March 31, 2024, the remaining open foreign exchange contracts, carried at fair value, are hedging Indian rupee expenses and have a maturity of approximately twelve months or less. These foreign exchange contracts mature monthly as the foreign currency denominated expenses are paid and any gain or loss is offset against operating expense. Once the hedged item is recognized, the cash flow hedge is de-designated and subsequent changes in value are recognized in other income (expense), net, to offset changes in the value of the resulting non-functional currency monetary assets or liabilities. The notional amounts of these foreign exchange forward contracts in U.S. dollar equivalents were to buy $93.9 million and $109.6 million of Indian rupees as of March 31, 2024 and December 31, 2023, respectively. Balance Sheet Hedges Balance Sheet hedges consist of cash flow hedge contracts that have been de-designated and non-designated balance sheet hedges. These foreign exchange contracts are carried at fair value and either did not or no longer qualify for hedge accounting treatment and are not designated as hedging instruments. Changes in the value of the foreign exchange contracts are recognized in other income, net and offset the foreign currency gain or loss on the underlying net monetary assets or liabilities. The notional amounts of foreign currency purchase contracts open in U.S. dollar equivalents were to buy $10.9 million a nd $12.2 million of Indian rupees at March 31, 2024 and December 31, 2023, respectively. There were no open foreign currency contracts to sell at March 31, 2024 and December 31, 2023, respectively. The following table reflects the fair value amounts for designated and non-designated hedging instruments at March 31, 2024 and December 31, 2023 (in thousands): March 31, 2024 December 31, 2023 Fair Value Derivative Assets (i) Fair Value Derivative Liabilities (ii) Fair Value Derivative Assets (i) Fair Value Derivative Liabilities (ii) Designated hedging instruments Foreign currency forward contracts $ 348 $ 13 $ 340 $ 44 Non-designated hedging instruments Foreign currency forward contracts 86 — 146 — Total fair value of hedging instruments $ 434 $ 13 $ 486 $ 44 _____________ (i) Included in prepaid expenses and other current assets on the condensed consolidated balance sheets. (ii) Included in accrued liabilities on the condensed consolidated balance sheets. The Company presents its derivative assets and derivative liabilities at gross fair values in the condensed consolidated balance sheets. However, under the master netting agreements with the respective counterparties of the foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. The derivatives held by the Company are not subject to any credit contingent features negotiated with its counterparties. The Company is not required to pledge nor is entitled to receive cash collateral related to the above contracts. As of March 31, 2024 and December 31, 2023, there were no derivative assets or liabilities that were net settled under the master netting agreements. The Company evaluates prospectively as well as retrospectively the effectiveness of its hedge programs using statistical analysis. The before-tax effects of derivative instruments designated as cash flow hedges on the accumulated other comprehensive loss and condensed consolidated statements of operations for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 Amount of gain recognized in other comprehensive income (loss) (i) $ 357 $ 1,249 Amount of gain (loss) related to foreign exchange forward contracts reclassified from accumulated other comprehensive income (loss) into income (ii) $ 304 $ (1,160) _____________ (i) The before-tax gain of $357 related to foreign exchange forward contracts was recognized in other comprehensive loss during the three months ended March 31, 2024. The before-tax gain of $1,249 related to foreign exchange forward contracts was recognized in other comprehensive loss during the three months ended March 31, 2023. (ii) For the three months ended March 31, 2024, the before-tax gain of $73 and $231 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations. For the three months ended March 31, 2023, the before-tax loss of $(226) and $(934) were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations. The before-tax (loss) gain recognized in other income, net for non-designated foreign currency forward contracts for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 (Loss) gain recognized in other income, net $ (25) $ 65 See Note 5. Fair Value Measurements, and Note 14. Commitments and Contingencies in the Notes to Condensed Consolidated Financial Statements of this Report for a further discussion.

Stockholders Equity

Stockholders Equity	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Stockholders Equity	Note 11. Stockholders Equity Common and Preferred Stock The rights of the holders of Class A common stock and Class B-1 common stock are identical in all respects, except that Class B-1 common stock will not vote on the election or removal of directors. The holders of Class B-2 common stock have no participating rights (voting or otherwise), except for the right to vote on the election or removal of directors and will be entitled to a nominal annual dividend of CAD$15,000 in the aggregate. Equity Incentive Plans The Company’s equity incentive plans are administered by the Compensation Committee. The Company adopted the 2015 Equity Incentive Plan (the “2015 Plan”) and most recently amended and restated the 2015 Plan in October 2021. Under the 2015 Plan, the Company issued equity awards in the form of options to acquire shares of the Company. The options are not intended to qualify as incentive stock options within the meaning of Section 422 of the Internal Revenue Code. The term of the options granted under this plan is ten years with a vesting requirement of continued employment through the applicable vesting date, and in certain cases attainment of performance criteria (“performance-based options”). In connection with the adoption of the 2021 Plan (as defined below), the 2015 Plan was terminated with respect to future awards. The 2015 Plan continues to govern awards that were granted prior to the effectiveness of the 2021 Plan. In October 2021, the Company’s Compensation Committee adopted, and its stockholders approved, the 2021 Equity Incentive Plan (the "2021 Plan"), which became effective in connection with the IPO. As of March 31, 2024, a total of approximately 78.7 million shares of the Company’s Class A common stock has been reserved for issuance under the 2021 Plan. In addition, the shares reserved for issuance under the 2021 Plan includes any shares subject to awards granted under the 2015 Plan that, after the date the 2015 Plan was terminated, are cancelled, expire or otherwise terminate without having been exercised in full, are tendered to or withheld by the Company for payment of an exercise price or for tax withholding obligations, or are forfeited to or repurchased by the Company due to failure to vest (provided that the maximum number of shares that may be added to the 2021 Plan pursuant to this provision is 26,288,211 shares). Option Awards The following table summarizes the option award activity for the three months ended March 31, 2024 (in thousands, except share price, fair value and term): Number of Options Weighted- Weighted- Aggregate Total Service Performance- Outstanding at December 31, 2023 17,004 11,278 5,726 $ 17.27 5.59 $ 189,134 Exercised (1,775) (1,544) (231) $ 16.26 Forfeited or expired (29) (23) (6) $ 18.00 Outstanding at March 31, 2024 15,200 9,711 5,489 $ 17.38 5.47 $ 267,748 As of March 31, 2024, total unrecognized stock-based compensation expense related to unvested options was $4.7 million and is expected to be recognized over the remaining weighted-average vesting period of 2.91 years. Restricted Stock Units ("RSUs") and Performance Stock Units (“PSUs”) The Company issues RSUs to employees and directors under the 2021 Plan. RSUs vest upon the satisfaction of a service-based vesting condition only. The service-based condition for the majority of the employee awards is generally satisfied pro-rata over two The Company also issues PSUs to employees under the 2021 Plan. PSUs that are granted are subject to vesting conditions based on certain performance metrics or on attainment of specified stock prices, measured over the performance period. The PSU awards granted to employees under the 2021 Plan typically vest over 3 years and are subject to forfeiture in whole if employment terminates, or in whole or in part, if specified vesting conditions are not satisfied in each case prior to vesting. PSUs are not considered issued or outstanding common stock until they vest. The following table summarizes RSU and PSU activity and related information during the three months ended March 31, 2024 under the 2021 Plan (in thousands, except share price): Number of Shares Weighted-Average Grant Date Fair Value Unvested and outstanding as of December 31, 2023 21,063 $ 20.81 Granted 4,165 32.37 Vested (3,268) 20.20 Forfeited (417) 20.18 Unvested and outstanding as of March 31, 2024 21,543 $ 23.15 As of March 31, 2024, the total unrecognized stock-based compensation expense related to the RSUs and PSUs and PSUs outstanding was $443.3 million and is expected to be recognized over the remaining weighted-average vesting period of 1.90 years. Employee Stock Purchase Plan (“ESPP”) In October 2021, the Company’s Compensation Committee approved the ESPP, which became effective in connection with the IPO. The ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. As of March 31, 2024, a total of 14.0 million shares of the Company’s Class A common stock has been reserved for issuance under the ESPP. Under the ESPP, eligible employees are able to acquire shares of Class A common stock by accumulating funds through payroll deductions. Offering periods are generally twelve months long and begin on March 1 and September 1 of each year. The purchase price for shares of the Company’s Class A common stock purchased under the ESPP is 85% of the lesser of the fair market value of the Company’s Class A common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. The ESPP also includes a reset provision for the purchase price if the stock price on the purchase date is less than the stock price on the first date of the offering period. As of March 31, 2024, the total unrecognized stock-based compensation expense related to the ESPP was $8.5 million and is expected to be recognized over the remaining offering period. Summary of Assumptions for ESPP The following table summarizes the weighted-average assumptions used in estimating the fair value of the ESPP for the offering periods during the three months ended March 31, 2024 and 2023 using the Black-Scholes pricing model: Three Months Ended March 31, 2024 2023 ESPP: Expected term (in years) 0.5 - 1.0 0.5 - 1.0 Expected volatility 40.3% - 43.5% 42.4% - 48.5% Risk-free interest rate 4.9% - 5.3% 5.2% - 5.1% Expected dividend yield — % — % Fair value of common stock $32.46 $17.06 Stock Compensation The stock-based compensation for all equity awards for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 8,153 $ 7,366 Research and development 18,236 13,252 Sales and marketing 18,942 14,453 General and administrative 18,770 15,271 Total stock-based compensation $ 64,101 $ 50,342

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 12. Income Taxes The Company computes its income tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income or loss from recurring operations and adjusting for discrete tax items arising in that quarter. The Company's income tax benefit was $25.5 million on pretax losses of $16.1 million for the three months ended March 31, 2024, which resulted in a positive effective tax rate of 158%. The Company’s effective tax rate differs from the U.S. statutory rate of 21% primarily due to an increase in its valuation allowance and to a lesser extent from foreign income taxed at different rates and non-deductible stock-based compensation. The Company's income tax expense was $59.6 million on pretax losses of $56.8 million for the three months ended March 31, 2023, which resulted in a negative effective tax rate of 105%. The Company’s effective tax rate differs from the U.S. statutory rate of 21% primarily due to an increase in its valuation allowance and to a lesser extent from foreign income taxed at different rates and non-deductible stock-based compensation. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. In assessing the need for any additional valuation allowance as of March 31, 2024, the Company considered all available evidence both positive and negative, including potential for prudent and feasible tax planning strategies. As a result of this analysis for the three months ended March 31, 2024, management believes it is more likely than not that the Company’s deferred tax assets, after recorded valuation allowances for partial U.S. Federal and State deferred tax assets, and operating loss carryforwards in certain non-U.S. jurisdictions, will be realized.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended March 31, 2024 2023 Net income (loss) $ 9,334 $ (116,354) Weighted-average shares in computing net income (loss) per share: Basic 296,897 284,886 Effect of dilutive securities 15,602 — Diluted 312,499 284,886 Net income (loss) per share attributable to Class A and Class B-1 common stockholders: Basic $ 0.03 $ (0.41) Diluted $ 0.03 $ (0.41) The following potentially dilutive securities were excluded from the computation of diluted net income (loss) per share calculations for the periods presented because the impact of including them would have been anti-dilutive (in thousands): Three Months Ended March 31, 2024 2023 Stock options outstanding — 2,776 RSUs 9 711 PSUs — 170 ESPP 52 89

Commitment and Contingencies

Commitment and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 14. Commitments and Contingencies Long-Term Purchase Obligations As of March 31, 2024, the Company had long-term purchase obligations of approximately $135.4 million, primarily related to multi-year contracts with third party vendors for cloud services related to its subscription services and software as a service commitments. The expected payments under these commitments total approximately $91.9 million and $43.5 million over the next 1 year and 1-3 years, respectively. Warranties The Company generally provides product warranties. These are not separate performance obligations and are outside the scope of ASC 606. To date, the Company’s product warranty expense and obligations have not been material. The Company’s customer agreements generally include certain provisions for indemnifying the customer against losses, expenses, liabilities, and damages that may be awarded against the customer in the event the Company’s product is found to infringe upon a patent, copyright, trademark, or other proprietary right of a third party. The agreements generally limit the scope of and remedies for such indemnification obligations in a variety of industry-standard respects, including but not limited to certain time and scope limitations and a right to replace an infringing product with a non-infringing product. The Company believes its internal development processes and other policies and practices limit its exposure related to these indemnification provisions. In addition, the Company requires its employees to sign a proprietary information and inventions agreement, which assigns the rights to its employees’ development work to the Company. To date, the Company has not had to reimburse any of its customers for any losses related to these indemnification provisions, and no material claims against the Company are outstanding as of March 31, 2024 and December 31, 2023. The Company cannot determine the maximum amount of potential future payments, if any, related to such indemnification provisions due to the limited and infrequent history of prior indemnification claims. As permitted under Delaware law, the Company has agreements whereby the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was serving, at the Company’s request, in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company’s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal. The Company accrues for loss contingencies when available information indicates that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. Litigation The Company is a party to various legal proceedings and claims arising from the normal course of its business activities, including proceedings and claims related to employment and intellectual property related matters. The Company reviews the status of each matter and records a provision for a liability when it is considered both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed quarterly and adjusted as additional information becomes available. If both of the criteria are not met, the Company assesses whether there is at least a reasonable possibility that a loss, or additional losses, may be incurred. If there is a reasonable possibility that a material loss may be incurred, the Company discloses the estimate of the possible loss, range of loss, or a statement that such an estimate cannot be made. Litigation is subject to inherent uncertainties. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position and results of operation for the period in which the unfavorable outcome occurred, and potentially in future periods.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net income (loss)	$ 9,334	$ (116,354)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements include those of the Company and its subsidiaries, after elimination of all intercompany accounts and transactions. The Company has prepared the accompanying unaudited condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (the “SEC”).
Consolidation	In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual consolidated financial statements and reflect all adjustments, which include recurring adjustments necessary for the fair statement of the Company’s financial position as of March 31, 2024 and the results of operations for the three months ended March 31, 2024. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Segment Reporting	The Company manages, monitors and reports its operating results and financial position as a single operating segment. The Company’s chief operating decision-maker (“CODM”) is its Chief Executive Officer who makes operating decisions, assesses financial performance and allocates resources based on consolidated financial information. As such, the Company has determined that it operates in one reportable segment.
Use of Estimates	The Company’s unaudited condensed consolidated financial statements are prepared in accordance with GAAP, which require management to make certain estimates, judgments, and assumptions in determination of performance obligations and standalone selling price used in revenue recognition, the realizability of deferred tax assets, uncertain tax positions, and stock-based compensation. Management believes the estimates, judgments, and assumptions upon which it relies are reasonable based on information available at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the consolidated financial statements as well as the reported amounts of revenues and expenses during the periods presented. Any material differences between these estimates and actual results will impact the Company’s unaudited condensed consolidated financial statements. The Company assesses these estimates on a regular basis, however actual results could differ from estimates due to risks and uncertainties.
Summary of Significant Accounting Policies & Recent Accounting Pronouncements Not Yet Adopted	The Company’s significant accounting policies are discussed in “ Note 2. Basis of Presentation and Summary of Significant Accounting Policies In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.
Derivatives	The Company presents its derivative assets and derivative liabilities at gross fair values in the condensed consolidated balance sheets. However, under the master netting agreements with the respective counterparties of the foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. The derivatives held by the Company are not subject to any credit contingent features negotiated with its counterparties. The Company is not required to pledge nor is entitled to receive cash collateral related to the above contracts. As of March 31, 2024 and December 31, 2023, there were no derivative assets or liabilities that were net settled under the master netting agreements.
Warranties	Warranties The Company generally provides product warranties. These are not separate performance obligations and are outside the scope of ASC 606. To date, the Company’s product warranty expense and obligations have not been material. The Company’s customer agreements generally include certain provisions for indemnifying the customer against losses, expenses, liabilities, and damages that may be awarded against the customer in the event the Company’s product is found to infringe upon a patent, copyright, trademark, or other proprietary right of a third party. The agreements generally limit the scope of and remedies for such indemnification obligations in a variety of industry-standard respects, including but not limited to certain time and scope limitations and a right to replace an infringing product with a non-infringing product. The Company believes its internal development processes and other policies and practices limit its exposure related to these indemnification provisions. In addition, the Company requires its employees to sign a proprietary information and inventions agreement, which assigns the rights to its employees’ development work to the Company. To date, the Company has not had to reimburse any of its customers for any losses related to these indemnification provisions, and no material claims against the Company are outstanding as of March 31, 2024 and December 31, 2023. The Company cannot determine the maximum amount of potential future payments, if any, related to such indemnification provisions due to the limited and infrequent history of prior indemnification claims. As permitted under Delaware law, the Company has agreements whereby the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was serving, at the Company’s request, in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company’s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal. The Company accrues for loss contingencies when available information indicates that it is probable that an asset has been impaired or a liability has been incurred and the amount of the loss can be reasonably estimated. Litigation The Company is a party to various legal proceedings and claims arising from the normal course of its business activities, including proceedings and claims related to employment and intellectual property related matters. The Company reviews the status of each matter and records a provision for a liability when it is considered both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed quarterly and adjusted as additional information becomes available. If both of the criteria are not met, the Company assesses whether there is at least a reasonable possibility that a loss, or additional losses, may be incurred. If there is a reasonable possibility that a material loss may be incurred, the Company discloses the estimate of the possible loss, range of loss, or a statement that such an estimate cannot be made. Litigation is subject to inherent uncertainties. Were an unfavorable outcome to occur, there exists the possibility of a material adverse impact on the Company’s financial position and results of operation for the period in which the unfavorable outcome occurred, and potentially in future periods.

Cash, Cash Equivalents, and I_2

Cash, Cash Equivalents, and Investments (Tables)	3 Months Ended
	Mar. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents and Investments	The following table summarizes the Company’s cash, cash equivalents and investments as of March 31, 2024 and December 31, 2023 (in thousands). March 31, December 31, 2024 2023 Cash $ 176,516 $ 185,498 Cash equivalents: Time deposits 201,558 72,302 Money market funds 476,994 474,643 Total cash equivalents 678,552 546,945 Total cash and cash equivalents $ 855,068 $ 732,443 Short-term investments: Time deposits 150,805 153,550 Commercial paper 74,519 73,767 Corporate debt securities 3,986 3,964 U.S. government and agency securities 28,909 28,547 Total short-term investments $ 258,219 $ 259,828 Total cash, cash equivalents and investments $ 1,113,287 $ 992,271

Available-For-Sale Debt Secur_2

Available-For-Sale Debt Securities (Tables)	3 Months Ended
	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Debt Securities, Available-for-Sale	The following table summarizes the Company’s available-for-sale debt securities as of March 31, 2024 (in thousands). March 31, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. government securities $ 28,914 $ — $ (5) $ 28,909 Corporate debt securities 3,987 — (1) 3,986 Commercial paper 74,551 14 (46) 74,519 Total $ 107,452 $ 14 $ (52) $ 107,414 The following table summarizes the Company’s available-for-sale debt securities as of December 31, 2023 (in thousands). December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. government securities $ 18,596 $ 5 $ — $ 18,601 U.S. government agency securities 9,949 — (3) 9,946 Corporate debt securities 3,963 1 — 3,964 Commercial paper 73,701 76 (10) 73,767 Total $ 106,209 $ 82 $ (13) $ 106,278

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of March 31, 2024 and indicates the fair value hierarchy of the valuation (in thousands): Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Time deposits $ 352,363 $ 352,363 $ — $ — Money market funds 476,994 476,994 — — Commercial paper 74,519 — 74,519 — Corporate debt securities 3,986 — 3,986 — U.S. government securities 28,909 — 28,909 — Total cash equivalents and investments 936,771 829,357 107,414 — Foreign currency derivatives 434 — 434 — Total assets $ 937,205 $ 829,357 $ 107,848 $ — Liabilities: Foreign currency derivatives $ 13 $ — $ 13 $ — Total liabilities $ 13 $ — $ 13 $ — There were no transfers between Level 1, Level 2 and Level 3 categories during the three months ended March 31, 2024. The following table presents information about the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis as of December 31, 2023 and indicates the fair value hierarchy of the valuation (in thousands): Total Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Assets: Time deposits $ 225,852 $ 225,852 $ — $ — Money market funds 474,643 474,643 — — Commercial paper 73,767 — 73,767 — Corporate debt securities 3,964 — 3,964 — U.S. government and U.S. government agency securities 28,547 — 28,547 — Total cash equivalents and investments 806,773 700,495 106,278 — Foreign currency derivatives 486 — 486 — Total assets $ 807,259 $ 700,495 $ 106,764 $ — Liabilities: Foreign currency derivatives $ 44 $ — $ 44 $ — Total liabilities $ 44 $ — $ 44 $ —

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table presents the changes in the carrying amount of the goodwill for the three months ended March 31, 2024 (in thousands): Amount Ending balance as of December 31, 2023 $ 2,361,643 Foreign currency translation adjustment (12,524) Ending Balance as of March 31, 2024 $ 2,349,119
Schedule of Finite-Lived Intangible Assets	The carrying amounts of the intangible assets other than goodwill as of March 31, 2024 and December 31, 2023 are as follows (in thousands): March 31, 2024 December 31, 2023 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Acquired developed and core technology $ 880,694 $ (872,119) $ 8,575 $ 880,758 $ (871,085) $ 9,673 Other intangible assets: Customer relationships 2,157,036 (1,517,958) 639,078 2,159,179 (1,489,398) 669,781 Trade names and trademark 81,609 (77,110) 4,499 81,651 (73,931) 7,720 Total other intangible assets 2,238,645 (1,595,068) 643,577 2,240,830 (1,563,329) 677,501 Total intangible assets, net $ 3,119,339 $ (2,467,187) $ 652,152 $ 3,121,588 $ (2,434,414) $ 687,174
Schedule of Indefinite-Lived Intangible Assets	The carrying amounts of the intangible assets other than goodwill as of March 31, 2024 and December 31, 2023 are as follows (in thousands): March 31, 2024 December 31, 2023 Cost Accumulated Amortization Net Cost Accumulated Amortization Net Acquired developed and core technology $ 880,694 $ (872,119) $ 8,575 $ 880,758 $ (871,085) $ 9,673 Other intangible assets: Customer relationships 2,157,036 (1,517,958) 639,078 2,159,179 (1,489,398) 669,781 Trade names and trademark 81,609 (77,110) 4,499 81,651 (73,931) 7,720 Total other intangible assets 2,238,645 (1,595,068) 643,577 2,240,830 (1,563,329) 677,501 Total intangible assets, net $ 3,119,339 $ (2,467,187) $ 652,152 $ 3,121,588 $ (2,434,414) $ 687,174
Schedule of Finite-Lived Intangible Assets, Allocation of Amortization Expense	The allocation of the amortization of intangible assets for the periods indicated below is as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 1,034 $ 2,874 Operating expenses 31,739 34,291 Total amortization of intangible assets $ 32,773 $ 37,165
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of March 31, 2024, the amortization expense related to identifiable intangible assets in future periods is expected to be as follows (in thousands): Customer Relationships Intangible Asset Other Intangible Assets Total Intangible Assets Remaining 2024 $ 85,563 $ 7,367 $ 92,930 2025 99,611 2,127 101,738 2026 86,608 1,427 88,035 2027 75,156 686 75,842 2028 65,300 530 65,830 Thereafter 226,840 937 227,777 Total expected amortization expense $ 639,078 $ 13,074 $ 652,152

Borrowings (Tables)

Borrowings (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Debt	Long-term debt consists of the following (in thousands): March 31, 2024 December 31, 2023 Dollar term loan $ 1,837,500 $ 1,842,188 Less: Discount on term loan (6,161) (6,441) Less: Debt issuance costs (10,556) (11,037) Total debt, net of discount and debt issuance costs 1,820,783 1,824,710 Less: Current portion of long-term debt (18,750) (18,750) Long-term debt, net of current portion $ 1,802,033 $ 1,805,960
Schedule of Maturities of Long-term Debt	Future minimum principal payments on the Term Facility as of March 31, 2024 are as follows (in thousands): Remaining 2024 $ 14,062 2025 18,750 2026 18,750 2027 18,750 2028 1,767,188 Total $ 1,837,500

Disaggregation of Revenue, De_2

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the disaggregation of revenue by revenue type, consistent with how the Company evaluates its financial performance, for the three months ended March 31, 2024 and 2023 (in thousands): Three Months Ended March 31, 2024 2023 Revenues: Cloud subscription $ 151,438 $ 111,778 Self-managed subscription license 51,948 50,549 Self-managed subscription support and other 48,591 51,595 Subscription revenues 251,977 213,922 Perpetual license 21 806 Software revenue 251,998 214,728 Maintenance 117,678 125,375 Professional services 18,931 25,328 Maintenance and professional services revenue 136,609 150,703 Total revenues $ 388,607 $ 365,431 Revenue by geographic location for the three months ended March 31, 2024 and 2023 (in thousands): Three Months Ended March 31, 2024 2023 North America $ 258,055 $ 251,037 EMEA 86,710 77,002 Asia Pacific 32,980 29,596 Latin America 10,862 7,796 Total revenues $ 388,607 $ 365,431
Schedule of Capitalized Contract Cost	The changes in the capitalized costs to obtain a contract for the three months ended March 31, 2024 (in thousands): Amount Ending balance as of December 31, 2023 $ 237,991 Additions, net 11,583 Commissions amortized (20,453) Revaluation (1,746) Ending balance as of March 31, 2024 $ 227,375

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table reflects the fair value amounts for designated and non-designated hedging instruments at March 31, 2024 and December 31, 2023 (in thousands): March 31, 2024 December 31, 2023 Fair Value Derivative Assets (i) Fair Value Derivative Liabilities (ii) Fair Value Derivative Assets (i) Fair Value Derivative Liabilities (ii) Designated hedging instruments Foreign currency forward contracts $ 348 $ 13 $ 340 $ 44 Non-designated hedging instruments Foreign currency forward contracts 86 — 146 — Total fair value of hedging instruments $ 434 $ 13 $ 486 $ 44 _____________ (i) Included in prepaid expenses and other current assets on the condensed consolidated balance sheets. (ii) Included in accrued liabilities on the condensed consolidated balance sheets.
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The before-tax effects of derivative instruments designated as cash flow hedges on the accumulated other comprehensive loss and condensed consolidated statements of operations for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 Amount of gain recognized in other comprehensive income (loss) (i) $ 357 $ 1,249 Amount of gain (loss) related to foreign exchange forward contracts reclassified from accumulated other comprehensive income (loss) into income (ii) $ 304 $ (1,160) _____________ (i) The before-tax gain of $357 related to foreign exchange forward contracts was recognized in other comprehensive loss during the three months ended March 31, 2024. The before-tax gain of $1,249 related to foreign exchange forward contracts was recognized in other comprehensive loss during the three months ended March 31, 2023. (ii)
Schedule of Derivative Instruments, (Loss) Gain	The before-tax (loss) gain recognized in other income, net for non-designated foreign currency forward contracts for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 (Loss) gain recognized in other income, net $ (25) $ 65

Stockholders Equity (Tables)

Stockholders Equity (Tables)	3 Months Ended
	Mar. 31, 2024
Equity [Abstract]
Schedule of Share-based Payment Arrangement, Option, Activity	The following table summarizes the option award activity for the three months ended March 31, 2024 (in thousands, except share price, fair value and term): Number of Options Weighted- Weighted- Aggregate Total Service Performance- Outstanding at December 31, 2023 17,004 11,278 5,726 $ 17.27 5.59 $ 189,134 Exercised (1,775) (1,544) (231) $ 16.26 Forfeited or expired (29) (23) (6) $ 18.00 Outstanding at March 31, 2024 15,200 9,711 5,489 $ 17.38 5.47 $ 267,748
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	The following table summarizes RSU and PSU activity and related information during the three months ended March 31, 2024 under the 2021 Plan (in thousands, except share price): Number of Shares Weighted-Average Grant Date Fair Value Unvested and outstanding as of December 31, 2023 21,063 $ 20.81 Granted 4,165 32.37 Vested (3,268) 20.20 Forfeited (417) 20.18 Unvested and outstanding as of March 31, 2024 21,543 $ 23.15
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The following table summarizes the weighted-average assumptions used in estimating the fair value of the ESPP for the offering periods during the three months ended March 31, 2024 and 2023 using the Black-Scholes pricing model: Three Months Ended March 31, 2024 2023 ESPP: Expected term (in years) 0.5 - 1.0 0.5 - 1.0 Expected volatility 40.3% - 43.5% 42.4% - 48.5% Risk-free interest rate 4.9% - 5.3% 5.2% - 5.1% Expected dividend yield — % — % Fair value of common stock $32.46 $17.06
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount	The stock-based compensation for all equity awards for the periods indicated below are as follows (in thousands): Three Months Ended March 31, 2024 2023 Cost of revenues $ 8,153 $ 7,366 Research and development 18,236 13,252 Sales and marketing 18,942 14,453 General and administrative 18,770 15,271 Total stock-based compensation $ 64,101 $ 50,342

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Note 13. Net Income (Loss) Per Share The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data): Three Months Ended March 31, 2024 2023 Net income (loss) $ 9,334 $ (116,354) Weighted-average shares in computing net income (loss) per share: Basic 296,897 284,886 Effect of dilutive securities 15,602 — Diluted 312,499 284,886 Net income (loss) per share attributable to Class A and Class B-1 common stockholders: Basic $ 0.03 $ (0.41) Diluted $ 0.03 $ (0.41)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities were excluded from the computation of diluted net income (loss) per share calculations for the periods presented because the impact of including them would have been anti-dilutive (in thousands): Three Months Ended March 31, 2024 2023 Stock options outstanding — 2,776 RSUs 9 711 PSUs — 170 ESPP 52 89

Summary of Significant Accounti

Summary of Significant Accounting Policies - Segments (Details)	3 Months Ended
	Mar. 31, 2024 segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Cash, Cash Equivalents, and I_3

Cash, Cash Equivalents, and Investments - Schedule of Cash, Cash Equivalents and Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Cash and Cash Equivalents [Line Items]
Cash	$ 176,516	$ 185,498
Cash equivalents:
Time deposits	201,558	72,302
Money market funds	476,994	474,643
Total cash equivalents	678,552	546,945
Total cash and cash equivalents	855,068	732,443
Short-term investments:
Total short-term investments	258,219	259,828
Total cash, cash equivalents and investments	1,113,287	992,271
Time deposits
Short-term investments:
Total short-term investments	150,805	153,550
Commercial paper
Short-term investments:
Total short-term investments	74,519	73,767
Corporate debt securities
Short-term investments:
Total short-term investments	3,986	3,964
U.S. government and agency securities
Short-term investments:
Total short-term investments	$ 28,909	$ 28,547

Available-For-Sale Debt Secur_3

Available-For-Sale Debt Securities - Schedule of Debt Securities, Available-for-Sale (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	$ 107,452	$ 106,209
Unrealized Gains	14	82
Unrealized Losses	(52)	(13)
Fair Value	107,414	106,278
U.S. government securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	28,914	18,596
Unrealized Gains	0	5
Unrealized Losses	(5)	0
Fair Value	28,909	18,601
U.S. government agency securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost		9,949
Unrealized Gains		0
Unrealized Losses		(3)
Fair Value		9,946
Corporate debt securities
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	3,987	3,963
Unrealized Gains	0	1
Unrealized Losses	(1)	0
Fair Value	3,986	3,964
Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Amortized Cost	74,551	73,701
Unrealized Gains	14	76
Unrealized Losses	(46)	(10)
Fair Value	$ 74,519	$ 73,767

Available-For-Sale Debt Secur_4

Available-For-Sale Debt Securities - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Realized gains related to available-for-sale debt securities	$ 0
Fair value maturity of one year or less	107,400,000
Unrealized loss	52,000	$ 13,000
Available-for-sale debt securities in a continuous unrealized loss position for less than 12 months	77,200,000
Available-for-sale debt securities in a continuous unrealized loss position for more than 12 months	0
Credit losses	$ 0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Assets:
Total cash equivalents and investments	$ 936,771	$ 806,773
Total assets	937,205	807,259
Liabilities:
Total liabilities	13	44
Foreign currency derivatives
Assets:
Derivative assets	434	486
Liabilities:
Derivative liabilities	13	44
Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	829,357	700,495
Total assets	829,357	700,495
Liabilities:
Total liabilities	0	0
Quoted Prices in Active Markets for Identical Assets (Level 1) | Foreign currency derivatives
Assets:
Derivative assets	0	0
Liabilities:
Derivative liabilities	0	0
Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	107,414	106,278
Total assets	107,848	106,764
Liabilities:
Total liabilities	13	44
Significant Other Observable Inputs (Level 2) | Foreign currency derivatives
Assets:
Derivative assets	434	486
Liabilities:
Derivative liabilities	13	44
Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	0	0
Total assets	0	0
Liabilities:
Total liabilities	0	0
Significant Unobservable Inputs (Level 3) | Foreign currency derivatives
Assets:
Derivative assets	0	0
Liabilities:
Derivative liabilities	0	0
Time deposits
Assets:
Total cash equivalents and investments	352,363	225,852
Time deposits | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	352,363	225,852
Time deposits | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	0	0
Time deposits | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	0	0
Money market funds
Assets:
Total cash equivalents and investments	476,994	474,643
Money market funds | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	476,994	474,643
Money market funds | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	0	0
Money market funds | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	0	0
Commercial paper
Assets:
Total cash equivalents and investments	74,519	73,767
Commercial paper | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	0	0
Commercial paper | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	74,519	73,767
Commercial paper | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	0	0
Corporate debt securities
Assets:
Total cash equivalents and investments	3,986	3,964
Corporate debt securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	0	0
Corporate debt securities | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	3,986	3,964
Corporate debt securities | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	0	0
U.S. government securities
Assets:
Total cash equivalents and investments	28,909
U.S. government securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments	0
U.S. government securities | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments	28,909
U.S. government securities | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments	$ 0
U.S. government and U.S. government agency securities
Assets:
Total cash equivalents and investments		28,547
U.S. government and U.S. government agency securities | Quoted Prices in Active Markets for Identical Assets (Level 1)
Assets:
Total cash equivalents and investments		0
U.S. government and U.S. government agency securities | Significant Other Observable Inputs (Level 2)
Assets:
Total cash equivalents and investments		28,547
U.S. government and U.S. government agency securities | Significant Unobservable Inputs (Level 3)
Assets:
Total cash equivalents and investments		$ 0

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 2,361,643
Foreign currency translation adjustment	(12,524)
Goodwill, ending balance	$ 2,349,119

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
Cost	$ 3,119,339	$ 3,121,588
Accumulated Amortization	(2,467,187)	(2,434,414)
Net	652,152	687,174
Acquired developed and core technology
Finite-Lived Intangible Assets, Net [Abstract]
Cost	880,694	880,758
Accumulated Amortization	(872,119)	(871,085)
Net	8,575	9,673
Total other intangible assets
Finite-Lived Intangible Assets, Net [Abstract]
Cost	2,238,645	2,240,830
Accumulated Amortization	(1,595,068)	(1,563,329)
Net	643,577	677,501
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Cost	2,157,036	2,159,179
Accumulated Amortization	(1,517,958)	(1,489,398)
Net	639,078	669,781
Trade names and trademark
Finite-Lived Intangible Assets, Net [Abstract]
Cost	81,609	81,651
Accumulated Amortization	(77,110)	(73,931)
Net	$ 4,499	$ 7,720

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets and acquired technology	$ 32,773	$ 37,165

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Allocation of Amortization Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Total amortization of intangible assets	$ 32,773	$ 37,165
Cost of revenues
Finite-Lived Intangible Assets [Line Items]
Total amortization of intangible assets	1,034	2,874
Operating expenses
Finite-Lived Intangible Assets [Line Items]
Total amortization of intangible assets	$ 31,739	$ 34,291

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Remaining 2024	$ 92,930
2025	101,738
2026	88,035
2027	75,842
2028	65,830
Thereafter	227,777
Net	652,152	$ 687,174
Customer Relationships Intangible Asset
Finite-Lived Intangible Assets [Line Items]
Remaining 2024	85,563
2025	99,611
2026	86,608
2027	75,156
2028	65,300
Thereafter	226,840
Net	639,078
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Remaining 2024	7,367
2025	2,127
2026	1,427
2027	686
2028	530
Thereafter	937
Net	$ 13,074

Borrowings - Schedule of Debt (

Borrowings - Schedule of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Dollar term loan	$ 1,837,500
Less: Discount on term loan	(6,161)	$ (6,441)
Less: Debt issuance costs	(10,556)	(11,037)
Total debt, net of discount and debt issuance costs	1,820,783	1,824,710
Less: Current portion of long-term debt	(18,750)	(18,750)
Long-term debt, net of current portion	1,802,033	1,805,960
Dollar term loan | Medium-term Notes
Debt Instrument [Line Items]
Dollar term loan	$ 1,837,500	$ 1,842,188

Borrowings - Narrative (Details

Borrowings - Narrative (Details) - USD ($)		3 Months Ended
	Jul. 01, 2023	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-term debt		$ 1,820,783,000	$ 1,824,710,000
Fed Funds Effective Rate Overnight Index Swap Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.50%
Revolving Credit Facility | Minimum | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.11448%
Revolving Credit Facility | Maximum | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0.71513%
Medium-term Notes
Debt Instrument [Line Items]
Long-term debt, fair value		$ 1,841,200,000	1,848,300,000
Debt instrument, quarterly installment, percentage of original principal amount		0.25%
Debt instrument, original issue discount percentage	0.125%
Medium-term Notes | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1%
Medium-term Notes | Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1.75%
Medium-term Notes | Minimum | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	0%
Medium-term Notes | Minimum | Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1%
Medium-term Notes | Dollar term loan
Debt Instrument [Line Items]
Debt instrument, face amount		$ 1,900,000,000
Medium-term Notes | Dollar term loan | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	2.75%
Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Debt instrument, face amount		250,000,000
Long-term debt		0	0
Debt instrument, covenant, maximum net leverage ratio, aggregate principal amount of letter of credit obligations (more than)		$ 15,000,000
Debt instrument, covenant, maximum net leverage ratio, percent of principal in excess of revolving loan commitments		35%
Debt instrument, covenant, maximum net leverage		0.0625
Debt instrument, debt default, principal, additional interest rate		2%
Line of Credit | Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage		0.25%
Line of Credit | Revolving Credit Facility | Minimum | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	2%
Line of Credit | Revolving Credit Facility | Minimum | Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1%
Line of Credit | Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Line of credit facility, unused capacity, commitment fee percentage		0.35%
Line of Credit | Revolving Credit Facility | Maximum | SOFR
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	2.50%
Line of Credit | Revolving Credit Facility | Maximum | Base Rate
Debt Instrument [Line Items]
Debt instrument, basis spread on variable rate	1.50%
Line of Credit | Letter of Credit
Debt Instrument [Line Items]
Long-term debt		$ 1,600,000	$ 1,600,000
Line of credit facility, maximum borrowing capacity		30,000,000
Line of Credit | Bridge Loan
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity		$ 15,000,000

Borrowings - Contractual Obliga

Borrowings - Contractual Obligation, Fiscal Year Maturity (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Debt Disclosure [Abstract]
Remaining 2024	$ 14,062
2025	18,750
2026	18,750
2027	18,750
2028	1,767,188
Total	$ 1,837,500

Disaggregation of Revenue, De_3

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract - Disaggregation of Revenue by Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 388,607	$ 365,431
Software revenue
Disaggregation of Revenue [Line Items]
Total revenues	251,998	214,728
Subscription revenues
Disaggregation of Revenue [Line Items]
Total revenues	251,977	213,922
Cloud subscription
Disaggregation of Revenue [Line Items]
Total revenues	151,438	111,778
Self-managed subscription license
Disaggregation of Revenue [Line Items]
Total revenues	51,948	50,549
Self-managed Subscription Support and Other
Disaggregation of Revenue [Line Items]
Total revenues	48,591	51,595
Perpetual license
Disaggregation of Revenue [Line Items]
Total revenues	21	806
Maintenance and professional services
Disaggregation of Revenue [Line Items]
Total revenues	136,609	150,703
Maintenance
Disaggregation of Revenue [Line Items]
Total revenues	117,678	125,375
Professional services
Disaggregation of Revenue [Line Items]
Total revenues	$ 18,931	$ 25,328

Disaggregation of Revenue, De_4

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract - Revenue by Geographic Location (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenues	$ 388,607	$ 365,431
North America
Disaggregation of Revenue [Line Items]
Total revenues	258,055	251,037
EMEA
Disaggregation of Revenue [Line Items]
Total revenues	86,710	77,002
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenues	32,980	29,596
Latin America
Disaggregation of Revenue [Line Items]
Total revenues	$ 10,862	$ 7,796

Disaggregation of Revenue, De_5

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Total revenues	$ 388,607	$ 365,431
Deferred revenue	722,100		$ 786,700
Contract liabilities, revenue recognized	295,300	251,600
Revenue, remaining performance obligation, amount	1,500,000
Deferred commissions	227,375		$ 237,991
Prepaid Expenses and Other Current Assets
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred commissions	77,000
Other Assets
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred commissions	$ 150,400
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	66%
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months
UNITED STATES
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Total revenues	$ 242,000	$ 233,300

Disaggregation of Revenue, De_6

Disaggregation of Revenue, Deferred Revenue, Remaining Performance Obligations, Credit Risk and Capitalized Costs to Obtain a Contract - Capitalized Contract Costs (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Capitalized Contract Costs [Roll Forward]
Beginning balance	$ 237,991
Additions, net	11,583
Commissions amortized	(20,453)
Revaluation	(1,746)
Ending balance	$ 227,375

Restructuring (Details)

Restructuring (Details) $ in Millions			3 Months Ended	12 Months Ended
	Nov. 01, 2023 employee	Jan. 10, 2023 employee	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
January Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, number of positions eliminated | employee		450
Restructuring and related cost, number of positions eliminated, period percent		7%
Restructuring				$ 28.2
Impairment of right-of-use assets				1.1
November Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, number of positions eliminated | employee	500
Restructuring and related cost, number of positions eliminated, period percent	10%
Restructuring			$ 4.3	31.6
Impairment of right-of-use assets			0.5	$ 0.4
Payments for restructuring			$ 29.9

Derivative Financial Instrume_3

Derivative Financial Instruments - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Foreign currency cash flow hedge gain to be reclassified during next 12 months	$ 0.3
Foreign currency forward contracts
Derivative [Line Items]
Derivative, notional amount	93.9	$ 109.6
Foreign currency derivatives | Long
Derivative [Line Items]
Derivative, notional amount	$ 10.9	$ 12.2

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Derivative Instruments in Statement of Financial Position, Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Fair Value Derivative Assets	$ 434	$ 486
Accrued Liabilities
Derivative [Line Items]
Fair Value Derivative Liabilities	13	44
Designated hedging instruments | Foreign currency forward contracts | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Fair Value Derivative Assets	348	340
Designated hedging instruments | Foreign currency forward contracts | Accrued Liabilities
Derivative [Line Items]
Fair Value Derivative Liabilities	13	44
Foreign currency forward contracts | Foreign currency forward contracts | Prepaid Expenses and Other Current Assets
Derivative [Line Items]
Fair Value Derivative Assets	86	146
Foreign currency forward contracts | Foreign currency forward contracts | Accrued Liabilities
Derivative [Line Items]
Fair Value Derivative Liabilities	$ 0	$ 0

Derivative Financial Instrume_5

Derivative Financial Instruments - Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cost of revenues
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in other income (expense), net	$ 73	$ (226)
Operating expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in other income (expense), net	231	(934)
Foreign currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain recognized in other comprehensive income (loss)	357	1,249
Designated hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain recognized in other comprehensive income (loss)	357	1,249
Designated hedging instruments | Foreign currency forward contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain (loss) related to foreign exchange forward contracts reclassified from accumulated other comprehensive income (loss) into income	$ 304	$ (1,160)

Derivative Financial Instrume_6

Derivative Financial Instruments - Derivative Instruments, (Loss) Gain (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Foreign currency forward contracts | Other Income (Expense), Net
Derivative Instruments, Gain (Loss) [Line Items]
(Loss) gain recognized in other income, net	$ (25)	$ 65

Stockholders Equity - Narrative

Stockholders Equity - Narrative (Details) $ in Thousands, $ in Millions	1 Months Ended	3 Months Ended
	Oct. 31, 2021 shares	Mar. 31, 2024 CAD ($) shares	Mar. 31, 2024 USD ($) shares
2015 Stock Plan
Class of Stock [Line Items]
Share-based compensation arrangement by share-based payment award, expiration period		10 years
2021 Stock Plan
Class of Stock [Line Items]
Common stock, capital shares reserved for future issuance (in shares) | shares		78,700,000	78,700,000
Common stock, capital shares reserved for future issuance, maximum shares that may be added due to provision from previous plans (in shares) | shares	26,288,211
Service Based
Class of Stock [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, amount			$ 4.7
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition		2 years 10 months 28 days
RSUs | Minimum
Class of Stock [Line Items]
Award vesting period		2 years
RSUs | Maximum
Class of Stock [Line Items]
Award vesting period		4 years
PSUs
Class of Stock [Line Items]
Award vesting period		3 years
Restricted Stock Units And Performance Stock Units
Class of Stock [Line Items]
Share-based payment arrangement, nonvested award, cost not yet recognized, amount			$ 443.3
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition		1 year 10 months 24 days
ESPP
Class of Stock [Line Items]
Common stock, capital shares reserved for future issuance (in shares) | shares		14,000,000	14,000,000
Share-based payment arrangement, nonvested award, cost not yet recognized, amount			$ 8.5
Share-based compensation arrangement by share-based payment award, consecutive offering period	12 months
Share-based compensation arrangement by share-based payment award, percentage of market price, purchase date	85%
Class B-2 Common Stock
Class of Stock [Line Items]
Common stock, nominal annual dividend		$ 15

Stockholders Equity - Share-bas

Stockholders Equity - Share-based Payment Arrangement, Option, Activity (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Number of Options
Beginning balance (in shares)	17,004
Exercised (in shares)	(1,775)
Forfeited or expired (in shares)	(29)
Ending balance (in shares)	15,200	17,004
Weighted- Average Exercise Price
Weighted average exercise price, beginning balance (in shares)	$ 17.27
Weighted average exercise price, exercised (in shares)	16.26
Weighted average exercise price, Forfeited or expired (in shares)	18
Weighted average exercise price, ending balance (in shares)	$ 17.38	$ 17.27
Weighted- Average Remaining Contractual Term (in years)	5 years 5 months 19 days	5 years 7 months 2 days
Aggregate Intrinsic Value (in thousands)
Aggregate Intrinsic Value	$ 267,748	$ 189,134
Service Based
Number of Options
Beginning balance (in shares)	11,278
Exercised (in shares)	(1,544)
Forfeited or expired (in shares)	(23)
Ending balance (in shares)	9,711	11,278
Performance Based
Number of Options
Beginning balance (in shares)	5,726
Exercised (in shares)	(231)
Forfeited or expired (in shares)	(6)
Ending balance (in shares)	5,489	5,726

Stockholders Equity - Share-b_2

Stockholders Equity - Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Number of Shares
Unvested and outstanding, beginning balance (in shares) | shares	21,063
Granted (in shares) | shares	4,165
Vested (in shares) | shares	(3,268)
Forfeited (in shares) | shares	(417)
Unvested and outstanding, ending balance (in shares) | shares	21,543
Weighted-Average Grant Date Fair Value
Unvested and outstanding, beginning balance (in dollars per share) | $ / shares	$ 20.81
Granted (in dollars per share) | $ / shares	32.37
Vested (in dollars per share) | $ / shares	20.20
Forfeited (in dollars per share) | $ / shares	20.18
Unvested and outstanding, ending balance (in dollars per share) | $ / shares	$ 23.15

Stockholders Equity - Schedule

Stockholders Equity - Schedule of Valuation Assumptions (Details) - ESPP - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	40.30%	42.40%
Expected volatility, maximum	43.50%	48.50%
Risk-free interest rate, minimum	4.90%	5.20%
Risk-free interest rate, maximum	5.30%	5.10%
Expected dividend yield	0%	0%
Fair value of common stock (in dollars per share)	$ 32.46	$ 17.06
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	1 year	1 year

Stockholders Equity - Share-b_3

Stockholders Equity - Share-based Payment Arrangement, Expensed and Capitalized, Amount (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Class of Stock [Line Items]
Total stock-based compensation	$ 64,101	$ 50,342
Cost of revenues
Class of Stock [Line Items]
Total stock-based compensation	8,153	7,366
Research and development
Class of Stock [Line Items]
Total stock-based compensation	18,236	13,252
Sales and marketing
Class of Stock [Line Items]
Total stock-based compensation	18,942	14,453
General and administrative
Class of Stock [Line Items]
Total stock-based compensation	$ 18,770	$ 15,271

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	$ (25,464)	$ 59,569
Loss before income taxes	$ 16,130	$ 56,785
Effective tax rate (as a percent)	158%	(105.00%)

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule of Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Earnings Per Share [Abstract]
Net income (loss)	$ 9,334	$ (116,354)
Weighted-average shares in computing net income (loss) per share
Basic (in shares)	296,897	284,886
Effect of dilutive securities (in shares)	15,602	0
Diluted (in shares)	312,499	284,886
Net income (loss) per share attributable to Class A and Class B-1 common stockholders
Basic (in dollars per share)	$ 0.03	$ (0.41)
Diluted (in dollars per share)	$ 0.03	$ (0.41)

Net Income (Loss) Per Share -_2

Net Income (Loss) Per Share - Schedule of Dilutive Securities (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock options outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options outstanding (in shares)	0	2,776
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options outstanding (in shares)	9	711
PSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options outstanding (in shares)	0	170
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Stock options outstanding (in shares)	52	89

Commitment and Contingencies (D

Commitment and Contingencies (Details) $ in Millions	Mar. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 135.4
Purchase obligation, to be paid, year one	91.9
Purchase obligation, to be paid, year two and three	$ 43.5